Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes

References

• Selmi C. Autoimmunity in 2009. Autoimmun. Rev.9(12), 795–800 (2010).
   PubMedGoogle Scholar
• Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N. Engl. J. Med.347(12), 911–920 (2002).
   PubMed Web of Science ®Google Scholar
• Goldberg E, Krause I. Infection and Type 1 diabetes mellitus – a two edged sword? Autoimmun. Rev.8(8), 682–686 (2009).
   PubMedGoogle Scholar
• Hober D, Sane F. Enteroviral pathogenesis of Type 1 diabetes. Discov. Med.10(51), 151–160 (2010).
   PubMedGoogle Scholar
• Pallansch MA, Roos RP, Knipe DM. Enteroviruses: polioviruses, coxsackieviruses, echoviruses and newer enteroviruses. In: Fields Virology 2007 (5th Ed.). Lippincott Williams & Wilkins, PA, USA, 839–894 (2006).
   Google Scholar
• Oberste MS. Comparative genomics of the coxsackie B viruses and related enteroviruses. Curr. Top. Microbiol. Immunol.323, 33–47 (2008).
   PubMedGoogle Scholar
• Kallewaard NL, Zhang L, Chen JW, Guttenberg M, Sanchez MD, Bergelson JM. Tissue-specific deletion of the coxsackievirus and adenovirus receptor protects mice from virus-induced pancreatitis and myocarditis. Cell Host Microbe.6(1), 91–98 (2009).
   PubMedGoogle Scholar
• Tracy S, Oberste MS, Drescher KM. Group B coxsackieviruses. In: Current Topics in Microbiology and Immunology (Volume 323). Springer, Berlin, Germany 293–309 (2008).
   Google Scholar
• Jaïdane H, Hober D. Role of coxsackievirus B4 in the pathogenesis of Type 1 diabetes. Diabetes Metab.34(6 Pt 1), 537–548 (2008).
   PubMedGoogle Scholar
• Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human Type 1 diabetes. Diabetologia52(6), 1143–1151 (2009).
   PubMed Web of Science ®Google Scholar
• Knowlton KU. CVB infection and mechanisms of viral cardiomyopathy. Curr. Top. Micobiol. Immunol.323, 315–335 (2008).
   PubMed Web of Science ®Google Scholar
• Ylipaasto P, Klingel K, Lindberg AM et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet β cells. Diabetologia47(2), 225–39 (2004).
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Kerr-Conte J, Pattou F et al. Persistent infection of human pancreatic islets by coxsackievirus B is associated with α interferon synthesis in β cells. J. Virol.74(21), 10153–10164 (2000).
   PubMed Web of Science ®Google Scholar
• Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J. Virol.76(9), 4430–4440 (2002).
   PubMed Web of Science ®Google Scholar
• Chaplin DD. Overview of the immune response. J. Allergy Clin. Immunol.125(2 Suppl. 2), S3–S23 (2010).
   PubMed Web of Science ®Google Scholar
• Ylipaasto P, Kutlu B, Rasilainen S et al. Global profiling of coxsackievirus- and cytokine-induced gene expression in human pancreatic islets. Diabetologia48(8), 1510–1522 (2005).
   PubMedGoogle Scholar
• Rasschaert J, Ladrière L, Urbain M et al. Toll-like receptor 3 and STAT-1 contribute to double-stranded RNA+ interferon-γ-induced apoptosis in primary pancreatic β-cells. J. Biol. Chem.280(40), 33984–33991 (2005).
   PubMed Web of Science ®Google Scholar
• Dogusan Z, García M, Flamez D et al. Double-stranded RNA induces pancreatic β-cell apoptosis by activation of the Toll-like receptor 3 and interferon regulatory factor 3 pathways. Diabetes57(5), 1236–1245 (2008).
   PubMed Web of Science ®Google Scholar
• Haller O, Kochs G, Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology344(1), 119–130 (2006).
   PubMed Web of Science ®Google Scholar
• Hühn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodström-Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection. Virology401(1), 42–48 (2010).
   PubMedGoogle Scholar
• Nejentsev S, Walker N, Riches D, Egholm M, Todd JA. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against Type 1 diabetes. Science324(5925), 387–389 (2009).
   PubMed Web of Science ®Google Scholar
• Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and β-cell loss in Type 1 diabetes. Nat. Rev. Endocrinol.5(4), 219–226 (2009).
   PubMed Web of Science ®Google Scholar
• Triantafilou K, Orthopoulos G, Vakakis E et al. Human cardiac inflammatory responses triggered by coxsackie B viruses are mainly Toll-like receptor (TLR) 8-dependent. Cell Microbiol.7(8), 1117–1126 (2005).
   PubMed Web of Science ®Google Scholar
• Wang JP, Asher DR, Chan M, Kurt-Jones EA, Finberg RW. Cutting edge: antibody-mediated TLR7-dependent recognition of viral RNA. J. Immunol.178(6), 3363–3367 (2007).
   PubMed Web of Science ®Google Scholar
• Richer MJ, Lavallée DJ, Shanina I, Horwitz MS. Toll-like receptor 3 signaling on macrophages is required for survival following coxsackievirus B4 infection. PLoS ONE4(1), e4127 (2009).
   PubMed Web of Science ®Google Scholar
• Hultcrantz M, Hühn MH, Wolf M et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology367(1), 92–101 (2007).
   PubMed Web of Science ®Google Scholar
• Hühn MH, Hultcrantz M, Lind K, Ljunggren HG, Malmberg KJ, Flodström-Tullberg M. IFN-γ production dominates the early human natural killer cell response to coxsackievirus infection. Cell Microbiol.10(2), 426–436 (2008).
   PubMedGoogle Scholar
• von Herrath M. Diabetes: a virus-gene collaboration. Nature459(7246), 518–519 (2009).
   PubMedGoogle Scholar
• Hühn MH, McCartney SA, Lind K, Svedin E, Colonna M, Flodström-Tullberg M. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after coxsackievirus infection. Virology401(1), 42–48 (2010).
   PubMedGoogle Scholar
• Mena I, Perry CM, Harkins S, Rodriguez F, Gebhard J, Whitton JL. The role of B lymphocytes in coxsackievirus B3 infection. Am. J. Pathol.155(4), 1205–1215 (1999).
   PubMed Web of Science ®Google Scholar
• Misbah SA, Spickett GP, Ryba PC, Hockaday JM, Kroll JS, Sherwood C. Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review. J. Clin. Immunol.12(4), 266–270 (1992).
   PubMed Web of Science ®Google Scholar
• Schmugge M, Lauener R, Bossart W, Seger RA, Güngör T. Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment. Eur. J. Pediatr.158(12), 1010–1011 (1999).
   PubMed Web of Science ®Google Scholar
• Henke A, Huber S, Stelzner A, Whitton JL. The role of CD8+ T lymphocytes in coxsackievirus B3-induced myocarditis. J. Virol.69(11), 6720–6728 (1995).
   PubMed Web of Science ®Google Scholar
• Skarsvik S, Puranen J, Honkanen J et al. Decreased in vitro type 1 immune response against coxsackie virus B4 in children with Type 1 diabetes. Diabetes55(4), 996–1003 (2006).
   PubMed Web of Science ®Google Scholar
• Hober D, Sauter P. Pathogenesis of Type 1 diabetes mellitus: interplay between enterovirus and host. Nat. Rev. Endocrinol.6(5), 279–289 (2010).
   PubMed Web of Science ®Google Scholar
• Tauriainen S, Oikarinen S, Oikarinen M, Hyöty H. Enteroviruses in the pathogenesis of Type 1 diabetes. Semin. Immunopathol.33(1), 45–55 (2010).
   PubMedGoogle Scholar
• Hober D, Sane F. Enteroviruses and Type 1 diabetes. Br. Med. J.3, 342 (2011).
   Google Scholar
• Yeung WC, Rawlinson WD, Craig ME. Enterovirus infection and Type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. Br. Med. J.3, 342 (2011).
   Google Scholar
• Jaïdane H, Sauter P, Sane F, Goffard A, Gharbi J, Hober D. Enteroviruses and Type 1 diabetes: towards a better understanding of the relationship. Rev. Med. Virol.20(5), 265–280 (2010).
   PubMed Web of Science ®Google Scholar
• Di Lorenzo TP, Peakman M, Roep BO. Translational mini-review series on Type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin. Exp. Immunol.148(1), 1–16 (2007).
   PubMedGoogle Scholar
• Mariño E, Batten M, Groom J et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes57(2), 395–404 (2008).
   PubMed Web of Science ®Google Scholar
• Haverkos HW, Battula N, Drotman DP, Rennert OM. Enteroviruses and Type 1 diabetes mellitus. Biomed. Pharmacother.57(9), 379–385 (2003).
   PubMedGoogle Scholar
• Green J, Casabonne D, Newton R. Coxsackie B virus serology and Type 1 diabetes mellitus: a systematic review of published case–control studies. Diabet. Med.21, 507–514 (2004).
   PubMed Web of Science ®Google Scholar
• Gamble DR, Kinsley MJ, Fitzgerald MG et al. Viral antibodies in diabetes mellitus. Br. Med. J.3, 627–630 (1969).
   PubMed Web of Science ®Google Scholar
• Yoon JW, Austin M, Onodera T et al. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis (virus-induced diabetes mellitus). N. Engl. J. Med.300, 1173–1179 (1979).
   PubMed Web of Science ®Google Scholar
• Andréoletti L, Hober D, Hober-Vandenberghe C et al. Detection of coxsackie B virus RNA sequences in whole blood samples from adult patients at the onset of Type I diabetes mellitus. J. Med. Virol.52(2), 121–127 (1997).
   PubMedGoogle Scholar
• Schulte BM, Bakkers J, Lanke KH et al. Detection of enterovirus RNA in peripheral blood mononuclear cells of Type 1 diabetic patients beyond the stage of acute infection. Viral Immunol.23(1), 99–104 (2010).
   PubMed Web of Science ®Google Scholar
• Toniolo A, Maccari G, Federico G, Salvatoni A, Bianchi G, Baj A. Are enterovirus infections linked to the early stages of Type 1 diabetes? Presented at: American Society for Microbiology Meeting. San Diego, CA, USA, 23–27 May 2010 (Abstract).
   Google Scholar
• Yin H, Berg AK, Tuvemo T, Frisk G. Enterovirus RNA is found in peripheral blood mononuclear cells in a majority of Type 1 diabetic children at onset. Diabetes51(6), 1964–1971 (2002).
   PubMed Web of Science ®Google Scholar
• Moya-Suri V, Schlosser M, Zimmermann K, Rjasanowski I, Gürtler L, Mentel R. Enterovirus RNA sequences in sera of schoolchildren in the general population and their association with Type 1-diabetes-associated autoantibodies. J. Med. Microbiol.54(Pt 9), 879–883 (2005).
   PubMedGoogle Scholar
• Kawashima H, Ihara T, Ioi H et al. Enterovirus-related Type 1 diabetes mellitus and antibodies to glutamic acid decarboxylase in Japan. J. Infect.49(2), 147–151 (2004).
   PubMedGoogle Scholar
• Salminen KK, Vuorinen T, Oikarinen S et al. Isolation of enterovirus strains from children with preclinical Type 1 diabetes. Diabet. Med.21(2), 156–164 (2004).
   PubMedGoogle Scholar
• Dotta F, Censini S, van Halteren AG et al. Coxsackie B4 virus infection of β cells and natural killer cell insulitis in recent-onset Type 1 diabetic patients. Proc. Natl Acad. Sci. USA104(12), 5115–5120 (2007).
   PubMed Web of Science ®Google Scholar
• Sadeharju K, Hämäläinen AM, Knip M et al. Enterovirus infections as a risk factor for Type I diabetes: virus analyses in a dietary intervention trial. Clin. Exp. Immunol.132(2), 271–277 (2003).
   PubMedGoogle Scholar
• Sarmiento L, Cabrera-Rode E, Lekuleni L et al. Occurrence of enterovirus RNA in serum of children with newly diagnosed Type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of Type 1 diabetes. Autoimmunity40(7), 540–545 (2007).
   PubMed Web of Science ®Google Scholar
• Oikarinen M, Tauriainen S, Honkanen T et al. Detection of enteroviruses in the intestine of Type 1 diabetic patients. Clin. Exp. Immunol.151(1), 71–75 (2007).
   PubMedGoogle Scholar
• Roivainen M, Klingel K. Role of enteroviruses in the pathogenesis of Type 1 diabetes. Diabetologia52(6), 995–996 (2009).
   PubMed Web of Science ®Google Scholar
• Tracy S, Drescher KM. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, Type 1 diabetes. Ann. NY Acad. Sci.1103, 143–151 (2007).
   PubMed Web of Science ®Google Scholar
• Elfving M, Svensson J, Oikarinen S et al. Maternal enterovirus infection during pregnancy as a risk factor in offspring diagnosed with Type 1 diabetes between 15 and 30 years of age. Exp. Diabetes Res.2008, 271958 (2008).
   PubMedGoogle Scholar
• Lönnrot M, Salminen K, Knip M et al. Enterovirus RNA in serum is a risk factor for β-cell autoimmunity and clinical Type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group. J. Med. Virol.61(2), 214–220 (2000).
   PubMedGoogle Scholar
• Lönnrot M, Korpela K, Knip M et al. Enterovirus infection as a risk factor for β-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes49(8), 1314–1318 (2000).
   PubMedGoogle Scholar
• Oikarinen S, Martiskainen M, Tauriainen S et al. Enterovirus RNA in blood is linked to the development of Type 1 diabetes. Diabetes60(1), 276–279 (2011).
   PubMed Web of Science ®Google Scholar
• Jaidane H, Sané F, Gharbi J, Aouni M, Romond MB, Hober D. Coxsackievirus B4 and Type 1 diabetes pathogenesis: contribution of animal models. Diabetes Metab. Res. Rev.25, 591–603 (2009).
   PubMed Web of Science ®Google Scholar
• Foulis AK, Farquharson MA, Meager A. Immunoreactive α-interferon in insulin-secreting β cells in Type 1 diabetes mellitus. Lancet2(8573), 1423–1427 (1987).
   PubMed Web of Science ®Google Scholar
• Huang X, Yuang J, Goddard A et al. Interferon expression in the pancreases of patients with Type I diabetes. Diabetes44(6), 658–664 (1995).
   PubMed Web of Science ®Google Scholar
• See DM, Tilles JG. Pathogenesis of virus-induced diabetes in mice. J. Infect. Dis.171(5), 1131–1138 (1995).
   PubMed Web of Science ®Google Scholar
• Hyöty H. Enterovirus infections and Type 1 diabetes. Ann. Med.34(3), 138–147 (2002).
   PubMed Web of Science ®Google Scholar
• Yin H, Berg AK, Westman J, Hellerström C, Frisk G. Complete nucleotide sequence of a coxsackievirus B-4 strain capable of establishing persistent infection in human pancreatic islet cells: effects on insulin release, proinsulin synthesis, and cell morphology. J. Med. Virol.68(4), 544–557 (2002).
   PubMedGoogle Scholar
• Roivainen M, Ylipaasto P, Savolainen C, Galama J, Hovi T, Otonkoski T. Functional impairment and killing of human β cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia45(5), 693–702 (2002).
   PubMedGoogle Scholar
• Stewart TA, Hultgren B, Huang X, Pitts-Meek S, Hully J, MacLachlan NJ. Induction of Type I diabetes by interferon-α in transgenic mice. Science260(5116), 1942–1946 (1993).
   PubMed Web of Science ®Google Scholar
• Tam PE, Messner RP. Molecular mechanisms of coxsackievirus persistence in chronic inflammatory myopathy: viral RNA persists through formation of a double-stranded complex without associated genomic mutations or evolution. J. Virol.73(12), 10113–10121 (1999).
   PubMed Web of Science ®Google Scholar
• Duncan G, Pelletier I, Colbère-Garapin F. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus–receptor interactions. Virology241(1), 14–29 (1998).
   PubMedGoogle Scholar
• Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N. Diabetes induced by coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med.4(7), 781–785 (1998).
   PubMed Web of Science ®Google Scholar
• Serreze DV, Ottendorfer EW, Ellis TM, Gauntt CJ, Atkinson MA. Acceleration of Type 1 diabetes by a coxsackievirus infection requires a preexisting critical mass of autoreactive T-cells in pancreatic islets. Diabetes49(5), 708–711 (2000).
   PubMedGoogle Scholar
• Horwitz MS, Fine C, Ilic A, Sarvetnick N. Requirements for viral-mediated autoimmune diabetes: β-cell damage and immune infiltration. J. Autoimmun.16(3), 211–217 (2001).
   PubMedGoogle Scholar
• Horwitz MS, Ilic A, Fine C, Rodriguez E, Sarvetnick N. Presented antigen from damaged pancreatic β cells activates autoreactive T cells in virus-mediated autoimmune diabetes. J. Clin. Invest.109(1), 79–87 (2002).
   PubMed Web of Science ®Google Scholar
• Rasche S, Busick RY, Quinn A. GAD65-specific cytotoxic T lymphocytes mediate β-cell death and loss of function. Rev. Diabet. Stud.6(1), 43–53 (2009).
   PubMedGoogle Scholar
• Kaufman DL, Clare-Salzler M, Tian J et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature366(6450), 69–72 (1993).
   PubMed Web of Science ®Google Scholar
• Tisch R, Yang XD, Singer SM, Liblau RS, Fugger L, McDevitt HO. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature366(6450), 72–75 (1993).
   PubMed Web of Science ®Google Scholar
• Horwitz MS, Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol. Rev.169, 241–253 (1999).
   PubMed Web of Science ®Google Scholar
• Filippi CM, von Herrath MG. Viral trigger for Type 1 diabetes: pros and cons. Diabetes57(11), 2863–2871 (2008).
   PubMed Web of Science ®Google Scholar
• Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J. Clin. Invest.96(3), 1506–1511 (1995).
   PubMed Web of Science ®Google Scholar
• Elias D, Markovits D, Reshef T, van der Zee R, Cohen IR. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc. Natl Acad. Sci. USA87(4), 1576–1580 (1990).
   PubMed Web of Science ®Google Scholar
• Härkönen T, Lankinen H, Davydova B, Hovi T, Roivainen M. Enterovirus infection can induce immune responses that cross-react with β-cell autoantigen tyrosine phosphatase IA-2/IAR. J. Med. Virol.66, 340–350 (2002).
   PubMedGoogle Scholar
• Christen U, Edelmann KH, McGavern DB, Wolfe T, Coon B, Teague MK. A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes. J. Clin. Invest.114(9), 1290–1298 (2004).
   PubMed Web of Science ®Google Scholar
• Geenen V, Mottet M, Dardenne O et al. Thymic self-antigens for the design of a negative/tolerogenic self-vaccination against Type 1 diabetes. Curr. Opin. Pharmacol.10(4), 461–472 (2010).
   PubMed Web of Science ®Google Scholar
• Kecha-Kamoun O, Achour I, Martens H et al. Thymic expression of insulin-related genes in an animal model of autoimmune Type 1 diabetes. Diabetes Metab. Res. Rev.17(2), 146–152 (2001).
   PubMed Web of Science ®Google Scholar
• Geenen V, Kroemer G. Multiple ways to cellular immune tolerance. Immunol. Today14(12), 573–575 (1993).
   PubMedGoogle Scholar
• Chatterjee NK, Hou J, Dockstader P, Charbonneau T. Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J. Med. Virol.38(2), 124–131 (1993).
   Google Scholar
• Brilot F, Chehadeh W, Charlet-Renard C, Martens H, Geenen V, Hober D. Persistent infection of human thymic epithelial cells by coxsackievirus B4. J. Virol.76(10), 5260–5265 (2002).
   PubMedGoogle Scholar
• Jaïdane H, Gharbi J, Lobert PE et al. Prolonged viral RNA detection in blood and lymphoid tissues from coxsackievirus B4 E2 orally-inoculated Swiss mice. Microbiol. Immunol.50(12), 971–974 (2006).
   PubMedGoogle Scholar
• Brilot F, Geenen V, Hober D, Stoddart CA. Coxsackievirus B4 infection of human fetal thymus cells. J. Virol.78(18), 9854–9861 (2004).
   PubMedGoogle Scholar
• Brilot F, Jaïdane H, Geenen V, Hober D. Coxsackievirus B4 infection of murine foetal thymus organ cultures. J. Med. Virol.80(4), 659–66 (2008).
   PubMedGoogle Scholar
• Takada A, Kawaoka Y. Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications. Rev. Med. Virol.13(6), 387–398 (2003).
   PubMed Web of Science ®Google Scholar
• Hober D, Chehadeh W, Bouzidi A, Wattré P. Antibody-dependent enhancement of coxsackievirus B4 infectivity of human peripheral blood mononuclear cells results in increased interferon-α synthesis. J. Infect. Dis.184(9), 1098–1108 (2001).
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Bouzidi A, Alm G, Wattré P, Hober D. Human antibodies isolated from plasma by affinity chromatography increase the coxsackievirus B4-induced synthesis of interferon-α by human peripheral blood mononuclear cells in vitro. J. Gen. Virol.82(Pt 8), 1899–1907 (2001).
   PubMedGoogle Scholar
• Sauter P, Lobert PE, Lucas B et al. Role of the capsid protein VP4 in the plasma-dependent enhancement of the coxsackievirus B4E2-infection of human peripheral blood cells. Virus Res.125(2), 183–190 (2007).
   PubMedGoogle Scholar
• Hober D, Chehadeh W, Weill J et al. Circulating and cell-bound antibodies increase coxsackievirus B4-induced production of IFN-α by peripheral blood mononuclear cells from patients with Type 1 diabetes. J. Gen. Virol.83(Pt 9), 2169–2176 (2002).
   PubMed Web of Science ®Google Scholar
• Chehadeh W, Lobert PE, Sauter P et al. Viral protein VP4 is a target of human antibodies enhancing coxsackievirus B4- and B3-induced synthesis of α interferon. J. Virol.79(22), 13882–13891 (2005).
   PubMedGoogle Scholar
• Sauter P, Chehadeh W, Lobert PE et al. A part of the VP4 capsid protein exhibited by coxsackievirus B4 E2 is the target of antibodies contained in plasma from patients with Type 1 diabetes. J. Med. Virol.80(5), 866–878 (2008).
   PubMed Web of Science ®Google Scholar
• Kishimoto C, Kurokawa M, Ochiai H. Antibody-mediated immune enhancement in coxsackievirus B3 myocarditis. J. Mol. Cell. Cardiol.34(9), 1227–1238 (2002).
   PubMed Web of Science ®Google Scholar
• Girn J, Kavoosi M, Chantler J. Enhancement of coxsackievirus B3 infection by antibody to a different coxsackievirus strain. J. Gen. Virol.83(Pt 2), 351–358 (2002).
   PubMed Web of Science ®Google Scholar
• Sauter P, Hober D. Mechanisms and results of the antibody-dependent enhancement of viral infections and role in the pathogenesis of coxsackievirus B-induced diseases. Microbes Infect.11(4), 443–445 (2009). Erratum in: Microbes Infect.11(14–15), 1219 (2009).
   PubMed Web of Science ®Google Scholar
• Tracy S, Drescher KM, Chapman NM et al. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol.76(23), 12097–12111 (2002).
   PubMedGoogle Scholar
• Filippi CM, Estes EA, Oldham JE, von Herrath MG. Immunoregulatory mechanisms triggered by viral infections protect from Type 1 diabetes in mice. J. Clin. Invest.119(6), 1515–1523 (2009).
   PubMed Web of Science ®Google Scholar
• Tracy S, Höfling K, Pirruccello S, Lane PH, Reyna SM, Gauntt CJ. Group B coxsackievirus myocarditis and pancreatitis: connection between viral virulence phenotypes in mice. J. Med. Virol.62(1), 70–81 (2000).
   PubMed Web of Science ®Google Scholar
• Drescher KM, Kono K, Bopegamage S, Carson SD, Tracy S. Coxsackievirus B3 infection and Type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. Virology329(2), 381–394 (2004).
   PubMedGoogle Scholar
• Bach JF. Infections and autoimmune diseases. J. Autoimmun.25(Suppl.), 74–80 (2005).
   PubMed Web of Science ®Google Scholar
• Tracy S, Drescher KM, Jackson JD, Kim K, Kono K. Enteroviruses, Type 1 diabetes and hygiene: a complex relationship. Rev. Med. Virol.20(2), 106–116 (2010).
   PubMedGoogle Scholar
• TEDDY Study Group. The Environmental Determinents of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes8, 286–298 (2007).
   PubMed Web of Science ®Google Scholar